Ipamorelin
ResearchIpamorelin
- Category
- Growth Hormone
- Aliases
- NNC 26-0161
- Administration
- Subcutaneous injection
Research and regulatory
Development stage
Phase II completed (postoperative ileus); not approved.
Legal and regulatory
Unscheduled research compound.
Side effects
Mild water retention, flushing, hunger